risedronate sodium
ItalyDrugs containing this active substance
-
The drug is used for the treatment of osteoporosis in postmenopausal women and, in some formulations, also in men at high risk of fractures. Other versions are indicated for Paget's disease of bone.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: THERAMEX IRELAND LIMITED
-
It is used to treat osteoporosis in postmenopausal women (to reduce the risk of vertebral or hip fractures) and in men at high risk of fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: SPA SOCIETA' PRODOTTI ANTIBIOTICI S.P.A.
-
The medicine is used for the treatment of osteoporosis in postmenopausal women and, in some formulations, also for the prevention of osteoporosis or for the treatment of osteoporosis in men at high risk of fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: THERAMEX IRELAND LIMITED
-
It is used for the treatment of osteoporosis in postmenopausal women (to reduce the risk of spinal and hip fractures) and in men at high risk of fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: GENETIC S.P.A.
-
It is used for the treatment of osteoporosis in postmenopausal women (including in cases of severe osteoporosis) and in men, with the aim of reducing the risk of vertebral and hip fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: DYMALIFE PHARMACEUTICAL S.R.L.
-
It is used for the treatment of osteoporosis in post-menopausal women and in men at high risk of fractures, acting on the bones to make them stronger.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: ACCORD HEALTHCARE, S.L.U.
-
It is used for the treatment of osteoporosis in postmenopausal women. It acts on the bones to make them stronger and less prone to fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: ACCORD HEALTHCARE, S.L.U.
-
It is used for the treatment of osteoporosis in both postmenopausal women (to reduce the risk of spinal and hip fractures) and in men at high risk of fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: LABORATORI ALTER S.R.L.
-
This medicine is used for the treatment of osteoporosis in postmenopausal women and in men, or for the prevention of osteoporosis in women at risk. Some versions of the drug are also indicated for the treatment of Paget's disease of the bone.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: AUROBINDO PHARMA (ITALIA) S.R.L.
-
It is used for the treatment of osteoporosis in postmenopausal women and in men, with the aim of strengthening bones and reducing the risk of fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: DOC GENERICI SRL
-
It is used for the treatment of osteoporosis in postmenopausal women, acting directly on the bones to strengthen them and reduce the risk of fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: DOC GENERICI SRL
-
This medicine is used for the treatment of osteoporosis (in post-menopausal women and in men) and for the treatment of Paget's disease of the bone.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: EG S.P.A.
-
It is used for the treatment of osteoporosis in postmenopausal women. It acts on the bones to make them stronger and less prone to fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: EG S.P.A.
-
It is used for the treatment of osteoporosis in postmenopausal women and in men. It works by strengthening the bones and reducing the risk of fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: MYLAN S.P.A.
-
It is used to treat osteoporosis in postmenopausal women (to reduce the risk of spinal and hip fractures) and in men at high risk of fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: SANDOZ S.P.A.
-
It is used for the treatment of osteoporosis in both postmenopausal women and men, with the aim of reducing the risk of vertebral and hip fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: TECNIGEN S.R.L.
-
It is used for the treatment of osteoporosis in both postmenopausal women and men, acting on the bones to make them stronger and less prone to fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: EURO-PHARMA S.R.L.
-
It is used for the treatment of osteoporosis in both postmenopausal women (including in cases of severe osteoporosis) and men, with the aim of reducing the risk of fractures.
Form: tablets, film-coated
Active substance Dosage risedronate sodium - ATC: M05BA07
Manufacturer: LANOVA FARMACEUTICI S.R.L.